Clinical Trials Directory

Trials / Unknown

UnknownNCT02131831

Telomeres Parameters in Cirrhosis

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

There are several factors that influence telomere length in patients with cirrhosis, such as metabolic derangements and infectious etiologies, The aim of the study is to compare telomere length and other parameters related to genetic instability in telomere/ telomerase system, in peripheral blood lymphocytes in cirrhosis from different etiologies.

Conditions

Timeline

Start date
2014-06-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-05-06
Last updated
2014-09-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02131831. Inclusion in this directory is not an endorsement.

Telomeres Parameters in Cirrhosis (NCT02131831) · Clinical Trials Directory